Sheila A M Rauch Selected Research

Sheila A M Rauch Research Topics

51	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2022 - 07/2013
13	Wounds and Injuries (Trauma) 01/2022 - 03/2015
2	Mental Disorders (Mental Disorder) 01/2022 - 10/2017
2	COVID-19 01/2022 - 01/2020
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2019
2	Marijuana Use 01/2019 - 01/2017
1	Pain (Aches) 07/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Chronic Pain 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 09/2018
1	Neurobehavioral Manifestations 03/2015
1	Symptom Flare Up 05/2014
1	Separation Anxiety (Separation Anxiety Disorder) 10/2013
1	Syndrome (Syndromes) 07/2013

11	Sertraline (Zoloft)FDA LinkGeneric 01/2022 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2021 - 03/2015
3	Biological ProductsIBA 11/2021 - 03/2015
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2021 - 05/2014
3	Cocaine (Cocaine HCl)IBA 01/2019 - 01/2017
2	Cycloserine (Seromycin)FDA Link 12/2020 - 10/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 01/2019
1	S-acetylthiorphanIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Inosine Triphosphate (ITP)IBA 11/2021
1	Aligeron (AS 2)IBA 11/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Pregnanolone (Allopregnanolone)IBA 01/2020
1	Illicit Drugs (Recreational Drugs)IBA 01/2019
1	Alprazolam (Xanax)FDA LinkGeneric 10/2018
1	BenzodiazepinesIBA 09/2018
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2017
1	A-factor (Streptomyces)IBA 10/2013

26	Therapeutics 07/2022 - 07/2013
2	Drug Therapy (Chemotherapy) 12/2021 - 01/2021
2	Transcranial Magnetic Stimulation 01/2021 - 12/2020
2	Duration of Therapy 01/2020 - 10/2017
1	Transcranial Direct Current Stimulation 07/2022
1	Aftercare (After-Treatment) 01/2022
1	VP-P protocol (DE protocol) 01/2022
1	Smart Glasses 12/2019
1	Contraindications 10/2019
1	Precision Medicine 10/2019